A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer
European Journal of Surgical Oncology · 2026-11 · 112367
DOI: 10.1016/j.ejso.2026.112367 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-11. Verfasst von Andrea Bertolucci und 8 weiteren Autor:innen. Beteiligte Einrichtung: Abdominal Surgery and Urology Department, Peritoneal Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Electronic address: a.berto…. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The peritoneal cancer index (PCI) is used both to predict resectability and to estimate prognosis in ovarian cancer. We aimed to identify the PCI threshold predicting incomplete cytoreduction at cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), and to describe its relation to survival. MATERIALS AND METHODS: Retrospective single-centre cohort of 112 consecutive patients with high-grade serous tubo-ovarian carcinoma treated with CRS and cisplatin HIPEC (2016-2023): 87 at interval CRS after neoadjuvant chemotherapy (primary population) and 25 at secondary CRS. PCI was related to residual disease (CC-1/2) with bootstrap-corrected ROC analysis and Firth regression, and to survival with Cox models and restricted mean survival time (RMST). RESULTS: At interval CRS, residual disease occurred in 10/26 patients (38%) with PCI > 14 and in 2/61 (3%) with PCI ≤ 14 (AUC 0.82; optimism-corrected 0.82). PCI > 14 was associated with shorter overall survival (median 27 vs 57 months; HR 2.15 (1.11-4.16)) and progression-free survival (RMST difference at 36 months -7.1 months, 95% CI -12.9 to -1.2). Small-bowel or mesenteric involvement, abstracted blind from operative reports, did not predict residual disease independently of PCI > 14. With complete cytoreduction (n = 75), each PCI point was associated with shorter overall survival (HR 1.07 (1.01-1.12)). CONCLUSION: At CRS-HIPEC for high-grade serous ovarian cancer, PCI > 14 identifies patients in whom complete cytoreduction is uncertain, reflecting total disease burden rather than small-bowel involvement alone. PCI retained prognostic information after complete cytoreduction. The threshold should guide surgical planning and counselling rather than exclusion, and requires external validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Abdominal Surgery and Urology Department, Peritoneal Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Electronic address: a.bertolucci@ao-pisa.toscana.it.
- Abdominal Surgery and Urology Department, Peritoneal Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
Zitieren
APA
Bertolucci, A., Rreka, E., Piccini, L., Greco, A., Musco, B., Ferrari, M., Ramacciotti, N., Faviana, P., & Lippolis, P. V. (2026). A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer. European Journal of Surgical Oncology, 112367. https://doi.org/10.1016/j.ejso.2026.112367
Vancouver
Bertolucci A, Rreka E, Piccini L, Greco A, Musco B, Ferrari M, et al. A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer. European Journal of Surgical Oncology. 2026:112367. doi:10.1016/j.ejso.2026.112367
BibTeX
@article{Bertolucci2026,
author = {Bertolucci, Andrea and Rreka, Erion and Piccini, Lorenzo and Greco, Alfonso and Musco, Barbara and Ferrari, Mauro and Ramacciotti, Niccolò and Faviana, Pinuccia and Lippolis, Piero Vincenzo},
title = {A peritoneal cancer index above 14 is associated with incomplete cytoreduction in cytoreductive surgery with HIPEC for high-grade serous ovarian cancer},
journal = {European Journal of Surgical Oncology},
year = {2026},
pages = {112367},
doi = {10.1016/j.ejso.2026.112367}
}
EUVIMED